Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2316671
Max Phase: Preclinical
Molecular Formula: C38H56N2O11S
Molecular Weight: 748.94
Molecule Type: Small molecule
Associated Items:
ID: ALA2316671
Max Phase: Preclinical
Molecular Formula: C38H56N2O11S
Molecular Weight: 748.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)/C(=N\OCC#Cc2cccs2)[C@H](C)[C@H]2OC(=O)O[C@@]21C
Standard InChI: InChI=1S/C38H56N2O11S/c1-12-28-38(8)33(50-36(44)51-38)23(4)29(39-46-17-13-15-26-16-14-18-52-26)21(2)20-37(7,45-11)32(24(5)30(41)25(6)34(43)48-28)49-35-31(42)27(40(9)10)19-22(3)47-35/h14,16,18,21-25,27-28,31-33,35,42H,12,17,19-20H2,1-11H3/b39-29+/t21-,22-,23+,24+,25-,27+,28-,31-,32-,33-,35+,37-,38-/m1/s1
Standard InChI Key: AKWFOBZIALPHTM-LFJGIEHRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 748.94 | Molecular Weight (Monoisotopic): 748.3605 | AlogP: 4.82 | #Rotatable Bonds: 7 |
Polar Surface Area: 151.65 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.93 | CX Basic pKa: 8.27 | CX LogP: 6.65 | CX LogD: 6.04 |
Aromatic Rings: 1 | Heavy Atoms: 52 | QED Weighted: 0.13 | Np Likeness Score: 1.09 |
1. Liang JH, An K, Lv W, Cushman M, Wang H, Xu YC.. (2013) Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides., 59 [PMID:23202851] [10.1016/j.ejmech.2012.10.054] |
Source(1):